Ala5 beta-Ala8 Neurokinin A

Neurotensin (8-13)

Neurotensin (8-13) Chemical Structure

Product Information

CAS Number: 60482-95-3

Product Categories

• Drug Discovery
• Inhibitor
• Neurological Disease
• Neurotensin Receptor

Services and Support

Quality and Packaging

• Quality Upgrade
• Quality Assurance
• Flexible Package Options

Company Services Overview

Products by Type

• Drug Discovery
  • Inhibitor
  • PROTAC
  • Vaccine Adjuvants
  • Impurities
  • Metabolites
  • ADCs
  • Pharmaceutical Excipients
  • APIs
  • GMP
  • Intermediates
• Chemistry
  • Chiral Compounds
  • Flavor & Fragrance
  • Natural Compounds
  • Stable Isotope Labelled Compounds
  • Superparamagnetic Iron Oxide Nano/Micro Particles Preparation
  • Main Product
• Life Science
  • Nanoemulsions
  • Oligonucleotides
  • Enzymes
  • Stem Cell Molecule
  • Fluorescent Probes
  • Chemiluminescent Substrates
  • Carbohydrates, Nucleosides & Nucleotides
  • Phospholipids

Services

• Nanoemulsions Technology
  • Nanoemulsions cGMP Manufacturing
  • Nanoemulsions Characterization
  • Process Development & Stabilization Strategies
• Analytical Services
  • XDC Analysis Services
  • Crystallization Services
  • Lab Testing Services
  • Animal Testing for Inhibitors
  • Contract Purification
  • Impurity Identification & Analysis Services
• Custom Synthesis
  • Glycogen Synthesis
  • Glycans Synthesis
  • Chiral Synthesis and Resolution
  • Nucleoside Synthesis Services
  • Nucleotide Synthesis Services
  • Carbohydrate Services
• AI Drug Discovery
  • Conjugated Drug Development
  • RNA Therapeutics Development
  • ADMET & Developability
• Drug Discovery
  • Microbial Fermentation Services
  • Targeted Protein Degradation Platform (PROTACs)
  • Drug design services
  • Integrated Services on Drug Discovery
• Aesthetic Medicine Ingredients Services
• RNA Technology
• BOC Nano TM Platform
• Bioconjugation
  • Isotope Labeling Services
  • Fluorescent Labeling Service
• Drug Delivery
  • Cell Based Drug Delivery
  • Hydrogel Drug Delivery
  • Liposome Drug Delivery
  • Microspheres Drug Delivery
  • Nanoparticle Drug Delivery
  • Nanotechnology in Drug Delivery
  • Peptide-Based Drug Delivery
  • Polymer-Based Drug Delivery
  • Exosome-Based Drug Delivery
  • Carbohydrate-Based Drug Delivery
  • mRNA Drug Delivery
  • RNA Drug Delivery
  • siRNA Drug Delivery

XDC Bioconjugation

• Conjugation Methods
  • Lys Conjugation
  • Cys Conjugation
  • Site-Specific Conjugation
  • Disulfide Conjugation
  • Enzymatic Conjugation
  • Mod-ADClink TM
  • ADC Linker Design
  • Antibody Modification and Conjugation
• Targeting Drug Delivery
  • Antibody-Drug Conjugates
  • Antibody-Oligonucleotide Conjugates
  • Peptide-Drug Conjugates
  • Small Molecule-Drug Conjugates
  • Peptide-Oligonucleotide Conjugates
  • Natural Products-Active Molecules Conjugates
• RNAi Delivery
  • GalNAc-siRNA Conjugates
  • Antibody-siRNA Conjugates
  • Peptide-siRNA Conjugates
  • Aptamer-Drug Conjugates
  • Antibody-PNA Conjugates

CDMO

• cGMP Capacity
• Ingredient Combination
• CMC
• Formulation Services
• Process Development
• Quality Control

License out

• Antibody Peptide Oligonucleotide Conjugation (APOC™)
• Glycosylated Antibody-Oligonucleotide Conjugates Technology (GlycoAOCT™)
• Lipid-based Chem Enhanced Delivery System (LipCeDS™)

About Us

• Webinar
• Events
• Privacy and how to get started
• Contact Us
• Support
• Careers
• Our Distributor
• Chemistry Scholarship Program